Talk: Dr. Gymama Slaughter "Advanced Healthcare Technologies"
Short Speaker Bio:
Dr. Gymama Slaughter is the Executive Director of the Old Dominion University (ODU)
Research Center for Bioelectronics, where she leads pioneering efforts to integrate clinical and
basic science in areas such as precision medicine, therapeutics, diagnostics, environmental
health, and women’s health. Collaborating across ODU and with external partners, she aligns
faculty expertise with government and industry initiatives to drive innovation. She co-developed
BioPaper™, a cutting-edge biomaterial that was successfully commercialized by Materic in 2023
to accelerate breakthroughs in life sciences and pharmaceutical research. Her research has been
consistently supported by the National Science Foundation (NSF), the National Institutes of
Health (NIH), the U.S. Army Medical Research and Materiel Command, the Andrew W. Mellon
Foundation, TEDCO Maryland Innovation Initiative, and the Maryland Industry Partnership. She
was recently recognized as one of Virginia Business magazine’s 100 People to Meet in 2024,
reflecting her impact and leadership in the field. Her honors include the NSF CAREER Award,
the NIH G-RISE Award, the Up and Coming UMBC Inventor Award, the Greater Richmond
Technology Council RichTech Educator Award, and the Richmond Joint Engineers Consortium
Community Service Award. As a dedicated mentor, Dr. Slaughter has guided numerous scholars
to prestigious achievements. Her mentorship has also enabled many students and professionals to
secure scholarships, internships, and long-term career success. In addition to her research and
mentorship, Dr. Slaughter serves as an Associate Editor for the IEEE Sensors Journal and Nature
Scientific Reports. She received a B.S. in Chemistry, M.S. in Chemical Engineering, and a Ph.D.
in Computer Engineering from Virginia Commonwealth University.
Abstract: Recent advancements in biosensors and bioelectronics have driven the development of point-of-care diagnostic systems that offer improved accuracy in terms of sensitivity, specificity, and
response time. This presentation focuses on our efforts to create affordable and widely
deployable healthcare technologies for underserved communities, where diseases such as
diabetes, cancer, human immunodeficiency virus (HIV), and cardiovascular conditions are
prevalent and exacerbated by the impact of COVID-19. I will begin by discussing the
development of a self-powered glucose monitoring system, which harnesses the biochemical
energy of glucose to generate bioelectricity for continuous blood glucose monitoring, with a
special focus on the innovation of smart biopatches. Additionally, I will explore the creation of
nanobiosensing systems for monitoring cancer and inflammatory biomarkers, aimed at
improving diagnostic outcomes for cancer and cardiovascular diseases. Finally, I will present our
latest research, including the development of a system for monitoring HIV drug adherence, and
our use of bacterial nanocellulose as a tissue scaffold for wound healing applications.